When Apple announced the Apple Watch Series 10 last week, an important health-tracking feature was once again conspicuous by its absence for shoppers in the US. Because of a patent row with the medical company Masimo, the Series 10’s blood oxygen monitor will be disabled again in Apple’s homeland. Apple is yet to strike a deal with Masimo to licence the technology and is only allowed to sell its devices in the US because the feature is disabled. The
…
Read more